The BISKUIT project (biosensor for a cost-efficient and rapid determination of immune status), funded by the state of Baden-Württemberg, has been successfully completed by BioCopy. As part... read more →
In the BIOPRO podcast, BioCopy CEO Dr. Günter Roth talks about BioCopy's innovative test method for determining immunity to infectious diseases. As part of the BISKUIT project,... read more →
T cell therapies open up promising therapeutic perspectives and are currently still limited to only a few specific areas of application. In the field of oncology, two... read more →
BioCopy will showcase in a webinar its biomolecule copier in collaboration with Sino Biological, a global leader in recombinant technology, at the Festival of Biologics USA Congress.... read more →
Unlike classical swine fever, there is no vaccine against African swine fever. However, it has enormous economic potential. Just one infected wild boar can lead to a... read more →
[minti_button link="https://biocopy.ch/wp-content/uploads/2021/03/20210323_BioCopy-Pressrelease-Future-Vaccines.pdf" target="_blank" color="custom" custom_color="#a4c610"... read more →
[minti_button link="https://biocopy.ch/wp-content/uploads/2021/02/Forbes_Spin-offs-to-watch-2021.pdf" target="_blank"... read more →
BioCopy and CureVac present their contribution to the Covid-19 pandemic to representatives of the European Parliament and the European Commission at a virtual conference held by the... read more →
The St. Galler Tagblatt addresses the corona pandemic and clearly shows where there are still gaps in pandemic control and defence, but also reveals who can help find... read more →